Successful liver transplantation for hilar cholangiocarcinoma

Julie K. Heimbach

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations


PURPOSE OF REVIEW: The purpose of this review is to present recent data demonstrating the success of neoadjuvant therapy followed by liver transplantation for hilar cholangiocarcinoma. RECENT FINDINGS: The most recent outcomes of a protocol involving neoadjuvant therapy followed by liver transplant for hilar cholangiocarcinoma, placed in context with the most recent data regarding outcomes for surgical resection, are discussed. Data involving the observation and management of an increased rate of vascular complications following this aggressive protocol are described. Additionally, factors which may predict disease recurrence along with the implications of these data on organ allocation policy are reviewed. SUMMARY: For patients with early stage hilar cholangiocarcinoma which is unresectable or arising in the setting of primary sclerosing cholangitis, neoadjuvant chemoradiotherapy followed by liver transplantation provides excellent survival benefit. Outcomes are notably superior to other treatment options, including resection. The protocol, however, requires extensive involvement and expertise from multiple specialties to ensure success.

Original languageEnglish (US)
Pages (from-to)384-388
Number of pages5
JournalCurrent Opinion in Gastroenterology
Issue number3
StatePublished - May 2008


  • Bile duct cancer
  • Hilar cholangiocarcinoma
  • Liver transplantation
  • Survival analysis

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Successful liver transplantation for hilar cholangiocarcinoma'. Together they form a unique fingerprint.

Cite this